Although numerous nonrandomized studies have reported a nonsignificant trend toward improved survival using continuous methods [ 218 – 225 ], 2 meta-analyses [ 226 , 227 ] report the absence of significant difference in hospital mortality between patients who receive continuous and intermittent renal replacement therapies.
← all excerpts
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.
1
—
—